CellThera

CellThera is a clinical-stage biotechnology company and healthcare provider headquartered in Brno, Czech Republic, specializing in the development of autologous cell-based therapies. The company focuses on regenerative medicine and immunotherapy, utilizing adipose-derived stem cells and dendritic cell vaccines to treat chronic and life-threatening conditions. CellThera's primary therapeutic areas include orthopedics, oncology, and vascular medicine, with a significant emphasis on osteoarthritis and various solid tumors. The company operates a state-of-the-art facility for cell processing and is a founding member of the International Consortium for Cell Therapy and Immunotherapy (ICCTI). Their approach leverages the patient's own biological material to stimulate healing and immune responses, aiming to provide personalized treatment options where conventional therapies have failed. CellThera is committed to advancing clinical research and maintaining high GMP standards in the production of its therapeutic products.